| Year |
Citation |
Score |
| 2024 |
Cisneros WJ, Walter M, Soliman SHA, Simons LM, Cornish D, Halle AW, Kim EY, Wolinsky SM, Shilatifard A, Hultquist JF. Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal. Biorxiv : the Preprint Server For Biology. PMID 38464055 DOI: 10.1101/2024.03.01.582881 |
0.508 |
|
| 2024 |
Rathore U, Haas P, Easwar Kumar V, Hiatt J, Haas KM, Bouhaddou M, Swaney DL, Stevenson E, Zuliani-Alvarez L, McGregor MJ, Turner-Groth A, Ochieng' Olwal C, Bediako Y, Braberg H, Soucheray M, ... ... Hultquist JF, et al. CRISPR-Cas9 screen of E3 ubiquitin ligases identifies TRAF2 and UHRF1 as regulators of HIV latency in primary human T cells. Mbio. e0222223. PMID 38411080 DOI: 10.1128/mbio.02222-23 |
0.563 |
|
| 2024 |
Yi B, Tanaka YL, Cornish D, Kosako H, Butlertanaka EP, Sengupta P, Lippincott-Schwartz J, Hultquist JF, Saito A, Yoshimura SH. Host ZCCHC3 blocks HIV-1 infection and production through a dual mechanism. Iscience. 27: 109107. PMID 38384847 DOI: 10.1016/j.isci.2024.109107 |
0.536 |
|
| 2023 |
Samer S, Thomas Y, Araínga M, Carter C, Shirreff LM, Arif MS, Avita JM, Frank I, McRaven MD, Thuruthiyil CT, Heybeli VB, Anderson MR, Owen B, Gaisin A, Bose D, ... ... Hultquist JF, et al. Blockade of TGF-β signaling reactivates HIV-1/SIV reservoirs and immune responses in vivo. Jci Insight. 8. PMID 37991025 DOI: 10.1172/jci.insight.176882 |
0.333 |
|
| 2023 |
Phillips Ii G, Rodriguez-Ortiz AE, Adewumi OM, Banner K, Adetunji A, Awolude OA, Olayinka OA, Simons LM, Hultquist JF, Ozer EA, Kapogiannis B, Kuhns LM, Garofalo R, Taiwo B, Birkett M, et al. Social/Sexual Networks of People Newly Diagnosed with HIV in Ibadan, Nigeria. Aids and Behavior. PMID 37812271 DOI: 10.1007/s10461-023-04200-2 |
0.306 |
|
| 2023 |
Haas KM, McGregor MJ, Bouhaddou M, Polacco BJ, Kim EY, Nguyen TT, Newton BW, Urbanowski M, Kim H, Williams MAP, Rezelj VV, Hardy A, Fossati A, Stevenson EJ, Sukerman E, ... ... Hultquist JF, et al. Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets. Nature Communications. 14: 6030. PMID 37758692 DOI: 10.1038/s41467-023-41442-z |
0.313 |
|
| 2023 |
Behrens RT, Rajashekar JK, Bruce JW, Evans EL, Hansen AM, Salazar-Quiroz N, Simons LM, Ahlquist P, Hultquist JF, Kumar P, Sherer NM. Exploiting a rodent cell block for intrinsic resistance to HIV-1 gene expression in human T cells. Mbio. e0042023. PMID 37676006 DOI: 10.1128/mbio.00420-23 |
0.602 |
|
| 2023 |
McLaren PJ, Porreca I, Iaconis G, Mok HP, Mukhopadhyay S, Karakoc E, Cristinelli S, Pomilla C, Bartha I, Thorball CW, Tough RH, Angelino P, Kiar CS, Carstensen T, Fatumo S, ... ... Hultquist JF, et al. Author Correction: Africa-specific human genetic variation near CHD1L associates with HIV-1 load. Nature. PMID 37670157 DOI: 10.1038/s41586-023-06591-7 |
0.416 |
|
| 2023 |
McLaren PJ, Porreca I, Iaconis G, Mok HP, Mukhopadhyay S, Karakoc E, Cristinelli S, Pomilla C, Bartha I, Thorball CW, Tough RH, Angelino P, Kiar CS, Carstensen T, Fatumo S, ... ... Hultquist JF, et al. Africa-specific human genetic variation near CHD1L associates with HIV-1 load. Nature. PMID 37532928 DOI: 10.1038/s41586-023-06370-4 |
0.544 |
|
| 2023 |
Vaidyanathan A, Taylor HE, Hope TJ, D'Aquila RT, Bartom ET, Hultquist JF, Peter ME. Analysis of the Contribution of 6-mer Seed Toxicity to HIV-1-Induced Cytopathicity. Journal of Virology. e0065223. PMID 37310263 DOI: 10.1128/jvi.00652-23 |
0.459 |
|
| 2023 |
Soliman SHA, Cisneros WJ, Iwanaszko M, Aoi Y, Ganesan S, Walter M, Zeidner JM, Mishra RK, Kim EY, Wolinsky SM, Hultquist JF, Shilatifard A. Enhancing HIV-1 latency reversal through regulating the elongating RNA Pol II pause-release by a small-molecule disruptor of PAF1C. Science Advances. 9: eadf2468. PMID 36888719 DOI: 10.1126/sciadv.adf2468 |
0.445 |
|
| 2022 |
Fernandez-de Céspedes MV, Hoffman HK, Carter H, Simons LM, Naing L, Ablan SD, Scheiblin DA, Hultquist JF, van Engelenburg SB, Freed EO. Rab11-FIP1C Is Dispensable for HIV-1 Replication in Primary CD4 T Cells, but Its Role Is Cell Type Dependent in Immortalized Human T-Cell Lines. Journal of Virology. 96: e0087622. PMID 36354340 DOI: 10.1128/jvi.00876-22 |
0.511 |
|
| 2022 |
Samer S, Thomas Y, Araínga M, Carter C, Shirreff LM, Arif MS, Avita JM, Frank I, McRaven MD, Thuruthiyil CT, Heybeli VB, Anderson MR, Owen B, Gaisin A, Bose D, ... ... Hultquist JF, et al. Blockade of TGF-β signaling reactivates HIV-1/SIV reservoirs and immune responses in vivo. Jci Insight. PMID 36125890 DOI: 10.1172/jci.insight.162290 |
0.385 |
|
| 2022 |
Packard TA, Schwarzer R, Herzig E, Rao D, Luo X, Egedal JH, Hsiao F, Widera M, Hultquist JF, Grimmett ZW, Messer RJ, Krogan NJ, Deeks SG, Roan NR, Dittmer U, et al. CCL2: a Chemokine Potentially Promoting Early Seeding of the Latent HIV Reservoir. Mbio. e0189122. PMID 36073812 DOI: 10.1128/mbio.01891-22 |
0.513 |
|
| 2022 |
Cisneros WJ, Cornish D, Hultquist JF. Application of CRISPR-Cas9 Gene Editing for HIV Host Factor Discovery and Validation. Pathogens (Basel, Switzerland). 11. PMID 36015010 DOI: 10.3390/pathogens11080891 |
0.461 |
|
| 2022 |
Yoh SM, Mamede JI, Lau D, Ahn N, Sánchez-Aparicio MT, Temple J, Tuckwell A, Fuchs NV, Cianci GC, Riva L, Curry H, Yin X, Gambut S, Simons LM, Hultquist JF, et al. Recognition of HIV-1 capsid by PQBP1 licenses an innate immune sensing of nascent HIV-1 DNA. Molecular Cell. PMID 35809572 DOI: 10.1016/j.molcel.2022.06.010 |
0.556 |
|
| 2022 |
Johnson JR, Crosby DC, Hultquist JF, Kurland AP, Adhikary P, Li D, Marlett J, Swann J, Hüttenhain R, Verschueren E, Johnson TL, Newton BW, Shales M, Simon VA, Beltrao P, et al. Global post-translational modification profiling of HIV-1-infected cells reveals mechanisms of host cellular pathway remodeling. Cell Reports. 39: 110690. PMID 35417684 DOI: 10.1016/j.celrep.2022.110690 |
0.552 |
|
| 2022 |
Hiatt J, Hultquist JF, McGregor MJ, Bouhaddou M, Leenay RT, Simons LM, Young JM, Haas P, Roth TL, Tobin V, Wojcechowskyj JA, Woo JM, Rathore U, Cavero DA, Shifrut E, et al. A functional map of HIV-host interactions in primary human T cells. Nature Communications. 13: 1752. PMID 35365639 DOI: 10.1038/s41467-022-29346-w |
0.602 |
|
| 2022 |
Selyutina A, Simons LM, Kirby KA, Bulnes-Ramos A, Hu P, Sarafianos SG, Hultquist JF, Diaz-Griffero F. TRIM5α Restriction of HIV-1-N74D Viruses in Lymphocytes Is Caused by a Loss of Cyclophilin A Protection. Viruses. 14. PMID 35215956 DOI: 10.3390/v14020363 |
0.578 |
|
| 2022 |
Luo Z, Li M, Li TW, Lv Z, Ye Z, Cisneros WJ, Zhang J, Yuan L, Hultquist JF, Migueles SA, Huang L, Zhu J, Jiang W. Differential Expression of CREM/ICER Isoforms Is Associated with the Spontaneous Control of HIV Infection. Mbio. e0197921. PMID 35041523 DOI: 10.1128/mbio.01979-21 |
0.568 |
|
| 2021 |
Selyutina A, Hu P, Miller S, Simons LM, Yu HJ, Hultquist JF, Lee K, KewalRamani VN, Diaz-Griffero F. GS-CA1 and lenacapavir stabilize the HIV-1 core and modulate the core interaction with cellular factors. Iscience. 25: 103593. PMID 35005542 DOI: 10.1016/j.isci.2021.103593 |
0.363 |
|
| 2021 |
Chai Q, Li S, Collins MK, Li R, Ahmad I, Johnson SF, Frabutt DA, Yang Z, Shen X, Sun L, Hu J, Hultquist JF, Peterlin BM, Zheng YH. HIV-1 Nef interacts with the cyclin K/CDK13 complex to antagonize SERINC5 for optimal viral infectivity. Cell Reports. 36: 109514. PMID 34380030 DOI: 10.1016/j.celrep.2021.109514 |
0.373 |
|
| 2021 |
Hiatt J, Cavero DA, McGregor MJ, Zheng W, Budzik JM, Roth TL, Haas KM, Wu D, Rathore U, Meyer-Franke A, Bouzidi MS, Shifrut E, Lee Y, Kumar VE, Dang EV, ... ... Hultquist JF, et al. Efficient generation of isogenic primary human myeloid cells using CRISPR-Cas9 ribonucleoproteins. Cell Reports. 35: 109105. PMID 33979618 DOI: 10.1016/j.celrep.2021.109105 |
0.309 |
|
| 2020 |
Lorenzo-Redondo R, Ozer EA, Achenbach CJ, D'Aquila RT, Hultquist JF. Molecular epidemiology in the HIV and SARS-CoV-2 pandemics. Current Opinion in Hiv and Aids. PMID 33186230 DOI: 10.1097/COH.0000000000000660 |
0.454 |
|
| 2020 |
Martin-Sancho L, Lewinski MK, Pache L, Stoneham CA, Yin X, Pratt D, Churas C, Rosenthal SB, Liu S, De Jesus PD, O'Neill AM, Gounder AP, Nguyen C, Pu Y, Oom AL, ... ... Hultquist JF, et al. Functional Landscape of SARS-CoV-2 Cellular Restriction. Biorxiv : the Preprint Server For Biology. PMID 33024967 DOI: 10.1101/2020.09.29.319566 |
0.313 |
|
| 2020 |
Du Y, Hultquist JF, Zhou Q, Olson A, Tseng Y, Zhang TH, Hong M, Tang K, Chen L, Meng X, McGregor MJ, Dai L, Gong D, Martin-Sancho L, Chanda S, et al. mRNA display with library of even-distribution reveals cellular interactors of influenza virus NS1. Nature Communications. 11: 2449. PMID 32415096 DOI: 10.1038/S41467-020-16140-9 |
0.369 |
|
| 2020 |
Selyutina A, Persaud M, Simons LM, Bulnes-Ramos A, Buffone C, Martinez-Lopez A, Scoca V, Di Nunzio F, Hiatt J, Marson A, Krogan NJ, Hultquist JF, Diaz-Griffero F. Cyclophilin A Prevents HIV-1 Restriction in Lymphocytes by Blocking Human TRIM5α Binding to the Viral Core. Cell Reports. 30: 3766-3777.e6. PMID 32187548 DOI: 10.1016/J.Celrep.2020.02.100 |
0.619 |
|
| 2019 |
Hüttenhain R, Xu J, Burton LA, Gordon DE, Hultquist JF, Johnson JR, Satkamp L, Hiatt J, Rhee DY, Baek K, Crosby DC, Frankel AD, Marson A, Harper JW, Alpi AF, et al. ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. Cell Host & Microbe. PMID 31253590 DOI: 10.1016/J.Chom.2019.05.008 |
0.584 |
|
| 2019 |
Hultquist JF, Hiatt J, Schumann K, McGregor MJ, Roth TL, Haas P, Doudna JA, Marson A, Krogan NJ. CRISPR-Cas9 genome engineering of primary CD4 T cells for the interrogation of HIV-host factor interactions. Nature Protocols. 14: 1-27. PMID 30559373 DOI: 10.1038/S41596-018-0069-7 |
0.557 |
|
| 2018 |
Batra J, Hultquist JF, Liu D, Shtanko O, Von Dollen J, Satkamp L, Jang GM, Luthra P, Schwarz TM, Small GI, Arnett E, Anantpadma M, Reyes A, Leung DW, Kaake R, et al. Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of Ebola Virus Replication. Cell. 175: 1917-1930.e13. PMID 30550789 DOI: 10.1016/J.Cell.2018.08.044 |
0.42 |
|
| 2018 |
Zhao N, Sebastiano V, Moshkina N, Mena N, Hultquist J, Jimenez-Morales D, Ma Y, Rialdi A, Albrecht R, Fenouil R, Sánchez-Aparicio MT, Ayllon J, Ravisankar S, Haddad B, Ho JSY, et al. Influenza virus infection causes global RNAPII termination defects. Nature Structural & Molecular Biology. PMID 30177761 DOI: 10.1038/S41594-018-0124-7 |
0.395 |
|
| 2018 |
Chen SH, Jang GM, Hüttenhain R, Gordon DE, Du D, Newton BW, Johnson JR, Hiatt J, Hultquist JF, Johnson TL, Liu YL, Burton LA, Ye J, Reichermeier KM, Stroud RM, et al. CRL4 targets Elongin C for ubiquitination and degradation to modulate CRL5 signaling. The Embo Journal. PMID 30166453 DOI: 10.15252/Embj.201797508 |
0.497 |
|
| 2018 |
Dornfeld D, Dudek AH, Vausselin T, Günther SC, Hultquist JF, Giese S, Khokhlova-Cubberley D, Chew YC, Krogan NJ, Garcia-Sastre A, Schwemmle M, Shaw ML. SMARCA2-regulated host cell factors are required for MxA restriction of influenza A viruses. Scientific Reports. 8: 2092. PMID 29391557 DOI: 10.1038/S41598-018-20458-2 |
0.404 |
|
| 2018 |
Binning JM, Smith AM, Hultquist JF, Craik CS, Caretta N, Campbell MG, Burton L, La Greca F, McGregor MJ, Ta HM, Bartholomeeusen K, Peterlin BM, Krogan NJ, Sevillano N, Cheng Y, et al. Fab-based inhibitors reveal ubiquitin independent functions for HIV Vif neutralization of APOBEC3 restriction factors. Plos Pathogens. 14: e1006830. PMID 29304101 DOI: 10.1371/Journal.Ppat.1006830 |
0.453 |
|
| 2016 |
Rauch BJ, Silvis MR, Hultquist JF, Waters CS, McGregor MJ, Krogan NJ, Bondy-Denomy J. Inhibition of CRISPR-Cas9 with Bacteriophage Proteins. Cell. PMID 28041849 DOI: 10.1016/J.Cell.2016.12.009 |
0.347 |
|
| 2016 |
Park RJ, Wang T, Koundakjian D, Hultquist JF, Lamothe-Molina P, Monel B, Schumann K, Yu H, Krupzcak KM, Garcia-Beltran W, Piechocka-Trocha A, Krogan NJ, Marson A, Sabatini DM, Lander ES, et al. A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors. Nature Genetics. PMID 27992415 DOI: 10.1038/Ng.3741 |
0.617 |
|
| 2016 |
Hultquist JF, Schumann K, Woo JM, Manganaro L, McGregor MJ, Doudna J, Simon V, Krogan NJ, Marson A. A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells. Cell Reports. 17: 1438-1452. PMID 27783955 DOI: 10.1016/J.Celrep.2016.09.080 |
0.597 |
|
| 2016 |
Heaton NS, Moshkina N, Fenouil R, Gardner TJ, Aguirre S, Shah PS, Zhao N, Manganaro L, Hultquist JF, Noel J, Sachs DH, Hamilton J, Leon PE, Chawdury A, Tripathi S, et al. Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection. Immunity. 44: 46-58. PMID 26789921 DOI: 10.1016/J.Immuni.2015.12.017 |
0.491 |
|
| 2016 |
Heaton NS, Moshkina N, Fenouil R, Gardner TJ, Aguirre S, Shah PS, Zhao N, Manganaro L, Hultquist JF, Noel J, Sachs D, Hamilton J, Leon PE, Chawdury A, Tripathi S, et al. Corrections to Targeting Viral Proteostasis Limits Influenza Virus, HIV, and Dengue Virus Infection. (Immunity 44, 46-58, January 19, 2016) Immunity. 44: 438. DOI: 10.1016/J.Immuni.2016.01.016 |
0.484 |
|
| 2015 |
Kane JR, Stanley DJ, Hultquist JF, Johnson JR, Mietrach N, Binning JM, Jónsson SR, Barelier S, Newton BW, Johnson TL, Franks-Skiba KE, Li M, Brown WL, Gunnarsson HI, Adalbjornsdóttir A, et al. Lineage-Specific Viral Hijacking of Non-canonical E3 Ubiquitin Ligase Cofactors in the Evolution of Vif Anti-APOBEC3 Activity. Cell Reports. 11: 1236-50. PMID 25981045 DOI: 10.1016/J.Celrep.2015.04.038 |
0.709 |
|
| 2014 |
Refsland EW, Hultquist JF, Luengas EM, Ikeda T, Shaban NM, Law EK, Brown WL, Reilly C, Emerman M, Harris RS. Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity. Plos Genetics. 10: e1004761. PMID 25411794 DOI: 10.1371/Journal.Pgen.1004761 |
0.825 |
|
| 2014 |
Land AM, Shaban NM, Evans L, Hultquist JF, Albin JS, Harris RS. APOBEC3F determinants of HIV-1 Vif sensitivity. Journal of Virology. 88: 12923-7. PMID 25142588 DOI: 10.1128/Jvi.02362-14 |
0.807 |
|
| 2013 |
McDougle RM, Hultquist JF, Stabell AC, Sawyer SL, Harris RS. D316 is critical for the enzymatic activity and HIV-1 restriction potential of human and rhesus APOBEC3B. Virology. 441: 31-9. PMID 23542011 DOI: 10.1016/J.Virol.2013.03.003 |
0.711 |
|
| 2012 |
Harris RS, Hultquist JF, Evans DT. The restriction factors of human immunodeficiency virus. The Journal of Biological Chemistry. 287: 40875-83. PMID 23043100 DOI: 10.1074/Jbc.R112.416925 |
0.718 |
|
| 2012 |
Refsland EW, Hultquist JF, Harris RS. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n. Plos Pathogens. 8: e1002800. PMID 22807680 DOI: 10.1371/Journal.Ppat.1002800 |
0.804 |
|
| 2012 |
Hultquist JF, McDougle RM, Anderson BD, Harris RS. HIV type 1 viral infectivity factor and the RUNX transcription factors interact with core binding factor β on genetically distinct surfaces. Aids Research and Human Retroviruses. 28: 1543-51. PMID 22725134 DOI: 10.1089/Aid.2012.0142 |
0.653 |
|
| 2012 |
Lackey L, Demorest ZL, Land AM, Hultquist JF, Brown WL, Harris RS. APOBEC3B and AID have similar nuclear import mechanisms. Journal of Molecular Biology. 419: 301-14. PMID 22446380 DOI: 10.1016/J.Jmb.2012.03.011 |
0.709 |
|
| 2012 |
Hultquist JF, Binka M, LaRue RS, Simon V, Harris RS. Vif proteins of human and simian immunodeficiency viruses require cellular CBFβ to degrade APOBEC3 restriction factors. Journal of Virology. 86: 2874-7. PMID 22205746 DOI: 10.1128/Jvi.06950-11 |
0.804 |
|
| 2012 |
Jäger S, Kim DY, Hultquist JF, Shindo K, LaRue RS, Kwon E, Li M, Anderson BD, Yen L, Stanley D, Mahon C, Kane J, Franks-Skiba K, Cimermancic P, Burlingame A, et al. Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection. Nature. 481: 371-5. PMID 22190037 DOI: 10.1038/Nature10693 |
0.82 |
|
| 2011 |
Hultquist JF, Lengyel JA, Refsland EW, LaRue RS, Lackey L, Brown WL, Harris RS. Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1. Journal of Virology. 85: 11220-34. PMID 21835787 DOI: 10.1128/Jvi.05238-11 |
0.735 |
|
| 2010 |
Albin JS, Haché G, Hultquist JF, Brown WL, Harris RS. Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function. Journal of Virology. 84: 10209-19. PMID 20686027 DOI: 10.1128/Jvi.00632-10 |
0.757 |
|
| 2009 |
Hultquist JF, Harris RS. Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS. Future Virology. 4: 605. PMID 20174454 DOI: 10.2217/Fvl.09.59 |
0.74 |
|
| Show low-probability matches. |